Healthcare Industry News: Mazor Robotics
News Release - August 28, 2019
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive OfficerAUSTIN, Texas, Aug. 28, 2019 -- (Healthcare Sales & Marketing Network) -- Harmonic Bionics, Inc. announced today that Christopher Prentice has been appointed Chief Executive Officer and member of the Harmonic Bionics Board of Directors effective immediately. Mr. Prentice succeeds Youngmok Yun, who is a co-founder of the company and who will remain in the role of Chief Technology Officer/Chief Operating Officer.
Christopher Prentice has over 20 years of medical device experience in both large strategic healthcare companies and in successful startup companies. Most recently he was Vice President of Commercial Integration at Medtronic. Prior to his position at Medtronic, he was CEO of Mazor Robotics, Inc. and Chief Commercial Officer of Mazor Robotics Ltd., companies that were acquired by Medtronic in December 2018. Prior to joining Mazor Robotics in 2010, he worked in finance at Tampa General Hospital and held sales positions at Intuitive Surgical. Chris started his career in the medical device industry in sales, marketing, and product management positions at Johnson & Johnson. He holds an undergraduate in engineering from the United States Military Academy at West Point and graduate degrees from Western New England University and the University of South Florida.
About Harmonic Bionics, Inc.
Harmonic Bionics was founded in 2016 as a spin-off of the ReNeu Robotics Lab at The University of Texas at Austin. Harmonic Bionics aims to significantly advance upper extremity therapy for stroke, spinal cord injury, and traumatic brain injury patients. The mission of Harmonic Bionics is to innovate the neurorehabilitation process with robotic technology so that patients and their caregivers have an improved quality of life.
Source: Harmonic Bionics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.